Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-22 Sale | 2024-02-22 8:04 pm | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 1,254 | $8.71 | $10,922 | 311,733 (Direct) | View |
2023-11-21 Sale | 2023-11-22 6:07 pm | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 1,378 | $10.29 | $14,180 | 331,206 (Direct) | View |
2023-11-14 Sale | 2023-11-16 6:16 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,482 | $10.22 | $25,366 | 346,839 (Direct) | View |
2023-10-16 Sale | 2023-10-18 6:54 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,482 | $9.03 | $22,412 | 334,321 (Direct) | View |
2023-09-14 Sale | 2023-09-18 6:08 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,482 | $9.89 | $24,547 | 336,803 (Direct) | View |
2023-08-22 Sale | 2023-08-24 6:05 pm | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 1,807 | $9.47 | $17,112 | 340,566 (Direct) | View |
2023-08-11 Sale | 2023-08-15 6:09 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,322 | $9.99 | $23,197 | 349,746 (Direct) | View |
2023-07-14 Sale | 2023-07-18 6:14 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,322 | $9.84 | $22,848 | 352,068 (Direct) | View |
2023-06-14 Sale | 2023-06-16 6:14 pm | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 2,322 | $10.69 | $24,822 | 354,390 (Direct) | View |
2023-06-08 Sale | 2023-06-12 6:08 pm | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 1,790 | $11.13 | $19,923 | 352,833 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-02 Option Award | 2024-04-04 6:17 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 300,000 | $0 | 1,947,040 (Direct) | View |
2024-04-02 Option Award | 2024-04-04 6:15 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | 100,000 | $0 | 338,636 (Direct) | View |
2024-04-02 Option Award | 2024-04-04 6:13 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Miller Aine SVP, DEV & HEAD OF IRE OFFICE | 37,500 | $0 | 171,034 (Direct) | View |
2024-04-02 Option Award | 2024-04-04 6:11 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | 100,000 | $0 | 360,684 (Direct) | View |
2024-04-02 Option Award | 2024-04-04 6:09 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 37,500 | $0 | 349,233 (Direct) | View |
2024-03-15 Option Award | 2024-03-19 6:06 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 2,704 | $8.64 | 1,647,040 (Direct) | View |
2024-03-15 Gift | 2024-03-19 6:06 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 10,900 | $0 | 1,647,040 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:14 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 37,196 | $8.92 | 1,651,336 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:11 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | 17,036 | $8.92 | 238,636 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:10 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Miller Aine SVP, DEV & HEAD OF IRE OFFICE | 11,782 | $8.92 | 133,534 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:08 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | 17,595 | $8.92 | 260,684 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:06 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 19,294 | $8.92 | 314,915 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-22 8:04 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 18,219 | $8.92 | 311,733 (Direct) | View |
Ownership | 2024-02-16 8:12 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Miller Aine SVP, Dev & Head of IRE Office | 0 | $0 | 182,816 (Direct) | View |
2023-12-21 Option Award | 2023-12-26 6:09 pm | N/A 2033-12-21 | Theravance Biopharma Inc. | TBPH | Grant Jeremy T Director | 38,080 | $0 | 38,080 (Direct) | View |
2023-11-20 Tax Withholding | 2023-11-22 6:16 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 15,804 | $10.37 | 1,688,532 (Direct) | View |
2023-11-20 Tax Withholding | 2023-11-22 6:14 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | 6,187 | $10.37 | 255,672 (Direct) | View |
2023-11-20 Tax Withholding | 2023-11-22 6:11 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | 7,363 | $10.37 | 278,279 (Direct) | View |
2023-11-20 Tax Withholding | 2023-11-22 6:10 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 12,630 | $10.37 | 334,209 (Direct) | View |
2023-11-20 Tax Withholding | 2023-11-22 6:07 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 7,982 | $10.37 | 331,206 (Direct) | View |
2023-10-30 Option Award | 2023-11-01 6:35 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 15,000 | $0 | 349,321 (Direct) | View |
2023-08-20 Tax Withholding | 2023-08-22 6:19 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 15,804 | $9.7 | 1,704,336 (Direct) | View |
2023-08-20 Tax Withholding | 2023-08-22 6:17 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | 7,114 | $9.7 | 261,859 (Direct) | View |
2023-08-20 Tax Withholding | 2023-08-22 6:15 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | 8,912 | $9.7 | 285,297 (Direct) | View |
2023-08-20 Tax Withholding | 2023-08-22 6:13 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 10,461 | $9.7 | 339,285 (Direct) | View |
2023-08-20 Tax Withholding | 2023-08-22 6:10 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 10,460 | $9.7 | 342,373 (Direct) | View |
2023-05-20 Tax Withholding | 2023-05-23 7:48 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER | 15,804 | $11.21 | 1,720,140 (Direct) | View |
2023-05-20 Tax Withholding | 2023-05-23 7:46 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Sawaf Aziz SVP & CHIEF FINANCIAL OFFICER | 8,744 | $11.21 | 268,973 (Direct) | View |
2023-05-20 Tax Withholding | 2023-05-23 7:44 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | 11,469 | $11.21 | 294,209 (Direct) | View |
2023-05-20 Tax Withholding | 2023-05-23 7:41 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT | 10,460 | $11.21 | 356,712 (Direct) | View |
2023-05-20 Tax Withholding | 2023-05-23 7:40 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS | 5,567 | $11.21 | 354,623 (Direct) | View |